A lancet is a small needle with a plastic or rubber coating that fits into the top of a lancing device. Lancing devices are pen-like instruments which are used in conjunction with a lancet to draw blood to be applied to a glucose strip. Many lancets come as a component of blood glucose monitoring kits, and can be adjusted for injection depth. Reusable lancets are not as effective as they are more dull and painful and increase the risk of infection.
The lancet and lancing device market can be segmented by setting, yielding two segments: personal and professional. In 2016, the largest segment in the total lancet and lancing device market was the personal segment. Personal lancets and lancing devices are used by individuals who use personal meters to perform self-monitoring blood glucose (SMBG) on a daily basis. CMS competitive bidding had a significant impact on the personal lancet and lancing device market after substantial reimbursement cuts in July 2013 and July 2016, respectively. Lancet reuse is also a limiter of growth in the personal segment. The professional market comprises safety lancets, which are used by clinicians and staff in the hospital or long term care settings to measure the blood glucose levels of their diabetic patients. Safety lancets are necessary to avoid the risk of needlestick injuries and the spread of blood-borne pathogens.
'
TABLE OF CONTENTS I
LIST OF FIGURES III
LIST OF CHARTS IV
EXECUTIVE SUMMARY 1
U.S. DIABETES MONITORING, TREATMENT AND DRUG DELIVERY MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 7
MARKET DEVELOPMENTS 9
PROCEDURE NUMBERS 10
PROCEDURE CODES INVESTIGATED 10
MARKETS INCLUDED 11
KEY REPORT UPDATES 13
VERSION HISTORY 13
RESEARCH METHODOLOGY 14
1.1 RESEARCH SCOPE 14
1.2 IDATA’S 9-STEP METHODOLOGY 14
Step 1: Project Initiation & Team Selection 14
Step 2: Prepare Data Systems and Perform Secondary Research 16
Step 3: Preparation for Interviews & Questionnaire Design 17
Step 4: Performing Primary Research 18
Step 5: Research Analysis: Establishing Baseline Estimates 20
Step 6: Market Forecast and Analysis 21
Step 7: Identify Strategic Opportunities 23
Step 8: Final Review and Market Release 24
Step 9: Customer Feedback and Market Monitoring 25
DISEASE OVERVIEW 26
2.1 INTRODUCTION 26
2.1.1 Types of Diabetes 26
2.1.2 Diabetes Complications 28
2.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes 30
2.1.4 Signs and Symptoms 31
2.1.5 Diabetes Monitoring 33
2.1.6 Treatment 35
2.1.7 Drug Delivery Systems 36
LANCET AND LANCING DEVICE MARKET 38
3.1 INTRODUCTION 38
3.2 MARKET OVERVIEW 40
3.3 MARKET ANALYSIS AND FORECAST 43
3.3.1 Total Lancet and Lancing Device Market 43
3.3.1.1 Personal Lancet and Lancing Device Market 45
3.3.1.2 Professional Lancet and Lancing Device Market 48
3.4 DRIVERS AND LIMITERS 50
3.4.1 Market Drivers 50
3.4.2 Market Limiters 50
3.5 COMPETITIVE MARKET SHARE ANALYSIS 53
ABBREVIATIONS 57
Chart 1 1: Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S., 2013 – 2023 3
Chart 1 2: Diabetes Monitoring, Treatment and Drug Delivery Market Overview, U.S., 2013 &2023 3
Chart 3 1: Lancet and Lancing Device Market by Segment, U.S., 2013 – 2023 41
Chart 3 2: Lancet and Lancing Device Market Breakdown, U.S., 2016 42
Chart 3 3: Lancet and Lancing Device Market Breakdown, U.S.,2023 42
Chart 3 4: Total Lancet and Lancing Device Market, U.S., 2013 – 2023 44
Chart 3 5: Personal Lancet and Lancing Device Market, U.S., 2013 – 2023 47
Chart 3 6: Professional Lancet and Lancing Device Market, U.S., 2013 – 2023 49
Chart 3 7: Leading Competitors, Lancet and Lancing Device Market, U.S., 2016 56
Figure 1 1: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2016 (1 of 2) 4
Figure 1 2: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2016 (2 of 2) 5
Figure 1 3: Companies Researched in this Report, U.S., 2016 6
Figure 1 4: Factors Impacting the Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S. (1 of 2) 7
Figure 1 5: Factors Impacting the Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S. (2 of 2) 8
Figure 1 6: Recent Events in the Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2013 – 2016 9
Figure 1 7: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016 10
Figure 1 8: Procedure Codes Investigated, U.S., 2016 10
Figure 1 9: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016 (1 of 2) 11
Figure 1 10: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016 (2 of 2) 12
Figure 1 11: Key Report Updates 13
Figure 1 12: Version History 13
Figure 2 1: Major Types of Diabetes and Related Pathologies, U.S., 2016 27
Figure 2 2: Risk Factors Associated with Type 1 and Type 2 Diabetes, U.S., 2016 31
Figure 2 3: Signs and Symptoms Associated with Type 1 and Type 2 Diabetes, U.S., 2016 32
Figure 3 1: Lancet and Lancing Device Market by Segment, U.S., 2013 – 2023 (US$M) 40
Figure 3 2: Total Lancet and Lancing Device Market, U.S., 2013 – 2023 43
Figure 3 3: Personal Lancet and Lancing Device Market, U.S., 2013 – 2023 46
Figure 3 4: Professional Lancet and Lancing Device Market, U.S., 2013 – 2023 48
Figure 3 5: Drivers and Limiters, Lancet and Lancing Device Market, U.S., 2016 52
Figure 3 6: Leading Competitors, Lancet and Lancing Device Market, U.S., 2016 55
Sanofi
Novo Nordisk
Eli Lilly
Medtronic
Johnson & Johnson
Becton Dickinson
Abbott
Roche
DexCom
Ascensia
Insulet
Trividia Health
Tandem
Nova Biomedical
Valeritas
